Toxic shock syndrome secondary prevention: Difference between revisions
No edit summary |
|||
| Line 5: | Line 5: | ||
== Secondary Prevention == | == Secondary Prevention == | ||
Several [[antibiotic]] regimens have been successful in eradicating group A [[streptococcus]] from the [[pharynx]] of chronic carriers (i.e., [[rifampin]] plus intramuscular [[Benzathine penicillin G|benzathine penicillin]] or a 10-day course of a second-generation [[cephalosporin]] or [[clindamycin]]) | One of the major complications of [[toxic shock syndrome]] is that it increase the risk of disease re-currency. This condition may be controlled by [[chemoprophylaxis]] of patients with a past medical history of [[Toxic shock syndrome|TSS]]. However, there are limited data concerning [[chemoprophylaxis]] for severe invasive group A [[Streptococcus|streptococcal]] or staphylococcal infections. | ||
Several [[antibiotic]] regimens have been successful in eradicating group A [[streptococcus]] from the [[pharynx]] of chronic carriers (i.e., [[rifampin]] plus intramuscular [[Benzathine penicillin G|benzathine penicillin]] or a 10-day course of a second-generation [[cephalosporin]] or [[clindamycin]]).<ref name="urlSevere Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics">{{cite web |url=http://pediatrics.aappublications.org/content/101/1/136.short |title=Severe Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics |format= |work= |accessdate=}}</ref><ref name="pmid19980033">{{cite journal |vauthors=Wylie A |title=Epithelioma of Soft Palate and Uvula |journal=Proc. R. Soc. Med. |volume=11 |issue=Laryngol Sect |pages=110–1 |year=1918 |pmid=19980033 |pmc=2066844 |doi= |url=}}</ref> | |||
__NOTOC__ | __NOTOC__ | ||
Revision as of 02:56, 16 May 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
|
Toxic shock syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Toxic shock syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Toxic shock syndrome secondary prevention |
|
Risk calculators and risk factors for Toxic shock syndrome secondary prevention |
Overview:
Secondary prevention strategies following toxic shock syndrome (TSS) include chemoprophylaxis for invasive group A streptococcus or staphylococcus carriers. Although it is still not certain to be helpful.
Secondary Prevention
One of the major complications of toxic shock syndrome is that it increase the risk of disease re-currency. This condition may be controlled by chemoprophylaxis of patients with a past medical history of TSS. However, there are limited data concerning chemoprophylaxis for severe invasive group A streptococcal or staphylococcal infections.
Several antibiotic regimens have been successful in eradicating group A streptococcus from the pharynx of chronic carriers (i.e., rifampin plus intramuscular benzathine penicillin or a 10-day course of a second-generation cephalosporin or clindamycin).[1][2]
References
- ↑ "Severe Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics".
- ↑ Wylie A (1918). "Epithelioma of Soft Palate and Uvula". Proc. R. Soc. Med. 11 (Laryngol Sect): 110–1. PMC 2066844. PMID 19980033.